Укр
Eng
On February 7, the Verkhovna Rada supported the so-called draft law on mobilization (No. 3562-IX) in the first reading. Members of Parliament of Ukraine submitted more than 4000 amendments to the draft law, which are currently being actively considered by the Verkhovna Rada Committee on National Security, Defense and Intelligence.
As soon as the pharmaceutical market began to recover from the adoption of the new List of OTC medicines prohibited for advertising, the Order of the Ministry of Health No. 1894 dated 02.11.2023 suspended its validity until 1 March 2024. In order to understand the legal implications of these developments, it is important to focus on certain aspects.
On October 17, the MOH approved legislation requiring the international non-proprietary name of medicines to be indicated on paper and electronic prescriptions along with the mandatory indication of the form and dosage.
On October 24, 2023, the Antimonopoly Committee of Ukraine provided advisory clarifications regarding the specifics of determining the product boundaries of the market in the presence of signs of individual or collective power of the buyer. It is about the Committee's new approach to the application of competition legislation. - Angelina Furman, LIGA:ZAKON.
As it is known, the Technical Regulations on Cosmetic Products shall come into effect on August 3, 2024. Responsible manufacturers of cosmetic products have already started preparing documentation to confirm the compliance of their cosmetics with the Technical Regulations' requirements.
In August 2023, President signed two draft laws that introduce new rules for the digital sphere in Ukraine. They provide a legal framework for the circulation of digital assets and services in Ukraine, amend the Civil Code of Ukraine, supplement the list of objects of civil rights with a new type of objects, and introduce comprehensive regulation in the form of a separate law. - Andrii Gorbatenko, Angelina Furman, LIGA:ZAKON Business
The "Bolar Rule" is a provision that does not recognize as an infringement of a patent for an original medicinal product the actions taken by the applicant of a generic medicinal product (analogue of an original medicinal product) for the purpose of conducting trials and state registration of such medicinal product until the expiry of the patent.
Ukraine has once again declared a battle against counterfeit medicines and is already working on a system for verifying medicines. Some see 2D coding as a panacea, while others see harsh penalties for counterfeiting. What does such a system look like in the world, what should Ukraine include in its reform plans to make the fight against counterfeiting real, and what can be done today?